The National Institute for Biological Standards and Control (NIBSC)
  • Login
  • My Account
  • Stay connected
  • Shopping Basket
  • Pay Now
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Biological reference materials
  • Current influenza standards
  • Quality control reagents
  • CJD Resource Centre
  • Result Reporting System (RRS)
  • Centre for AIDS Reagents
  • Ordering
  • Biological standards price list
  • Home  /  
  • Products  /  
  • Biological reference materials  /  
  • Sub category listing




Product NumberDescription
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
International Reference Preparation
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
International Standard
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
Influenza
00/442 Influenza anti B/Yamanashi/166/98 Serum
Influenza
00/498 Diphtheria Antitoxin Human IgG
Working standard single unit sales
00/500 Botulinum Type A-E Antitoxin, Human Serum
Non WHO Reference Material
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
Influenza
00/546 Influenza Antigen B/Johannesburg/5/99
Influenza
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
Influenza
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
Influenza
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
International Standard
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
Non WHO Reference Material
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
Non WHO Reference Material
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
International Standard
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
Non WHO Reference Material
01/420 Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)
International Reference Reagent
01/426 Meningococcal group Y polysaccharide
Non WHO Reference Material
01/450 Influenza anti B/Guangdong/120/2000 Serum
Influenza
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
Influenza
01/506 Botulinum type F antitoxin, equine
Non WHO Reference Material
01/508 Botulinum type C antitoxin, equine
Non WHO Reference Material
01/510 Botulinum Antitoxin Equine Type D
Non WHO Reference Material
01/512 Botulinum type G antitoxin, equine
Non WHO Reference Material
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
Non WHO Reference Material
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
Non WHO Reference Material
01/546 Influenza Antigen B/Guangdong/120/2000
Influenza
01/580 Thrombin, human(2nd International Standard)
International Standard
01/600 Anti-Toxoplasma IgG, Human(International Standard)
International Standard
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
International Standard
01/612 Influenza Virus infectious B/Hawaii/10/01
Influenza
01/614 Influenza Antigen A/New Caledonia/20/99
Influenza
02/102 Influenza anti A/Panama/2007/99 Serum
Influenza
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
Non WHO Reference Material
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
Non WHO Reference Material
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
Non WHO Reference Material
02/180 Anti-Meningococcal Serotype P2.2a mAb
Non WHO Reference Material
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
Non WHO Reference Material
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
Non WHO Reference Material
02/206 Factor XIII Plasma, Human (1st International Standard)
International Standard
02/210 HIV (antibody), 1st International Reference Panel
International Reference Preparation
02/226 IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent)
International Reference Reagent
02/228 IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent)
International Reference Reagent
02/230 Biotinylated Brad-5 (Bio-Brad-5)
Working Standard
02/232 Tetanus Toxoid (Non-Adsorbed)
Non WHO Reference Material
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent)
International Reference Reagent
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
Influenza
02/308 Anti-Meningococcal Serotype P3.4 mAb
Non WHO Reference Material
02/310 Anti-Meningococcal Serotype P3.15 mAb
Non WHO Reference Material
02/318 Botulinum Antitoxin Equine Type E
Non WHO Reference Material
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
Non WHO Reference Material
02/336 Influenza Antigen A/New Caledonia/20/99
Influenza
02/338 Influenza anti A/Panama/2007/99 Serum
Influenza
02/342 Protein C Plasma, Human(2nd International Standard)
International Standard
03/104 HTLV-1 (antibody) Monitor Sample
European Certification
03/110 Influenza anti B/Shangdong/9/97 Serum
Influenza
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
Non WHO Reference Material
03/124 Thrombopoietin ( Human rDNA derived)
Non WHO Reference Material
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
Non WHO Reference Material
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent)
International Reference Reagent
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent)
International Reference Reagent
03/152 Anti-HPA-1a (International Standard)
International Standard
03/164 Anti-B minimum potency reference preparation(International Standard)
International Standard
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
International Standard
03/182 Anti-Meningococcal Serotype P3.21 mAb
Non WHO Reference Material
03/188 Anti-A minimum potency reference preparation(International Standard)
International Standard
03/190 Anti-HPA-3a(minimum potency)(WHO Reference Reagent)
International Reference Reagent
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
International Standard
03/200 Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent)
International Reference Reagent
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
Non WHO Reference Material
03/212 Influenza anti A/Wyoming/03/03 Serum
Influenza
03/220 Influenza Antigen A/Wyoming/03/03
Influenza
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
Non WHO Reference Material
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
Non WHO Reference Material
03/228 Protein S, Plasma, Human(2nd International Standard)
International Standard
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
Non WHO Reference Material
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
Influenza
03/244 Influenza Antiserum A/chick/Germany/N/49
Influenza
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
Influenza
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
International Reference Preparation
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
Non WHO Reference Material
04/160 Influenza Virus infectious NYMC X-147
Influenza
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent)
International Reference Reagent
04/170 Influenza Virus infectious A/Wellington/1/2004
Influenza
04/172 Influenza Virus infectious IVR-139
Influenza
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
International Standard
04/198 Anti-Meningococcal Serotype P3.1 mAb
Non WHO Reference Material
04/202 Influenza Antigen B/ Jiangsu/10/2003
Influenza
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
International Standard
04/228 Influenza anti B/ Neuraminidase Serum
Influenza
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum
Influenza
04/246 Anti-Meningococcal Serogroup W-135 mAb
Non WHO Reference Material
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
Non WHO Reference Material
04/252 Protein C Concentrate, Human(1st International Standard)
International Standard
04/260 Influenza anti A/New Caledonia/20/99 HA Serum
Influenza
04/262 Influenza anti A/New York/55/2004 HA Serum
Influenza
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
Influenza
05/102 Influenza Virus infectious NYMC BX-7
Influenza
05/106 Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent)
International Reference Reagent
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
International Standard
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
International Standard
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
International Standard
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
International Standard
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
Non WHO Reference Material
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
Non WHO Reference Material
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
Influenza
05/236 Influenza anti A/Wisconsin/67/2005 Serum
Influenza
05/252 Influenza anti B Neuraminidase Serum
Influenza
06/108 Influenza Virus infectious IVR-116
Influenza
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
International Standard
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
International Standard
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
International Standard
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
International Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
Influenza
06/166 Antithrombin Concentrate, Human (3rd International Standard)
International Standard
06/170 Influenza Antigen A/New Caledonia/20/99
Influenza
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
Influenza
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
International Standard
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
International Standard
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
Influenza
0688 SARS CoV-1 spike S1 protein
NIBSC Repository - Research Use Only
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
Influenza
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
Influenza
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
Influenza
07/132 Influenza Virus infectious B/Malaysia/2506/2004
Influenza
07/144 Influenza Virus infectious IVR-145,
Influenza
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
Influenza
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
Influenza
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
International Standard
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
International Standard
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum
Influenza
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
International Reference Reagent
07/214 Positive Control for use in flow cytometry cross matching (FCXM)
European Certification
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
International Standard
07/222 RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent)
International Reference Reagent
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
International Standard
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
International Reference Reagent
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
Influenza
07/286 Monitor sample for HBsAg 0.05IU/ml
European Certification
07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml
European Certification
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
Influenza
07/296 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
Clinical Virology Network
07/298 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
Clinical Virology Network
07/300 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
Clinical Virology Network
07/304 Anti-D for assuring operator and test performance
Working Standard
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent)
International Reference Reagent
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
International Standard
07/318 Meningococcal Group C Polysaccharide
Non WHO Reference Material
07/328 Unfractionated Heparin (6th I.S.)
International Standard
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
Influenza
07/338 Influenza antiserum A/Anhui/1/05 (H5)
Influenza
07/348 Influenza Virus infectious NYMC X-171B
Influenza
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
International Standard
07/358 Influenza Virus infectious NIB-50
Influenza
07/362 Influenza Virus infectious IVR-149
Influenza
07/B498 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
Quality Control Reagent
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
Influenza
08/108 Influenza Virus Infectious NIBRG-91 (H9N2)
Influenza
08/118 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/120 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/126 Influenza Anti N1 Neuraminidase Serum SH485
Influenza
08/138 Influenza Virus Infectious B/Florida/4/2006
Influenza
08/140 Influenza Antigen B/Florida/4/2006
Influenza
08/142 Influenza antiserum A/Anhui/1/05 (H5)
Influenza
08/148 HLA Class II Positive Control
European Certification
08/154 Influenza Virus Infectious NIBRG-12 (H5N1)
Influenza
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1)
Influenza
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
International Standard
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
International Standard
08/174 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/176 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/178 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/180 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
Clinical Virology Network
08/184 Influenza Antigen B/Malaysia/2506/2004
Influenza
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
Influenza
08/204 Thyroid Stimulating Antibody (2nd I.S.)
International Standard
08/208 Influenza Antigen A/HongKong/1073/99 (H9N2)
Influenza
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
Influenza
08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
International Standard
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
Influenza
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
International Standard
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
Influenza
08/230 Streptodornase (2nd International Standard)
International Standard
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
Influenza
08/248 Influenza Virus Infectious NIBRG-107 VE2 30480
Influenza
08/250 Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1)
Influenza
08/252 Influenza Virus Infectious NIBRG-109 VE2 30490
Influenza
08/256 C1- Inhibitor, Concentrate (1st International Standard)
International Standard
08/258 Antithrombin, Plasma (3rd International Standard)
International Standard
08/262 C1 Inhibitor (Plasma)(1st International Standard)
International Standard
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
International Standard
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
Influenza
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
Influenza
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
International Standard
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
Influenza
08/300 Influenza Virus Infectious IVR-148
Influenza
08/304 Influenza virus infectious NYMC X-175C
Influenza
08/318 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network
08/320 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network
08/322 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network
08/324 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network
08/356 Influenza antiserum A/Japan/305/57 (H2)
Influenza
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
Influenza
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
Influenza
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
International Standard
09/130 Influenza Virus Infectious NIBRG-122
Influenza
09/132 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network
09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
International Standard
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
International Standard
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
International Standard
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
Influenza
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
International Standard
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
Non WHO Reference Material
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
International Standard
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
Influenza
09/182 VWF Factor Concentrate (2nd International Standard)
International Standard
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
Influenza
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
International Standard
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
International Standard
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
Influenza
09/222 Human anti-Haemophilus influenzae b reference serum
European Certification
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
International Standard
09/236 Influenza Virus Infectious IVR-153
Influenza
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
International Standard
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
International Standard
09/264 Fibrinogen Plasma (D)(3rd International Standard)
International Standard
09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived
Non WHO Reference Material
09/268 Influenza Virus Infectious NIBRG-121xp
Influenza
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
Non WHO Reference Material
09/274 Influenza Virus Infectious NYMC X-185
Influenza
09/280 Influenza Virus Infectious NIB-64
Influenza
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
International Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
International Standard
09/304 Influenza Virus Infectious IVR-155
Influenza
09/306 Influenza Virus Infectious NIBRG-147 (H2N2)
Influenza
09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay
Working standard single unit sales
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
Influenza
10/104 Reteplase Reference Material
Non WHO Reference Material
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum
Influenza
10/128 Diphtheria Polyclonal Antibody
Non WHO Reference Material
10/130 Diphtheria Monoclonal Antibody
Non WHO Reference Material
10/132 Tetanus Polyclonal Antibody
Non WHO Reference Material
10/134 Tetanus Monoclonal Antibody
Non WHO Reference Material
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
International Standard
10/142 Anti-HLA Control
European Certification
10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].
International Reference Reagent
10/168 Oral Poliovaccine Sabin Type 3 reference
International Reference Reagent
10/176 Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
10/178 Endotoxin (3rd International Standard)
International Standard
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent)
International Reference Reagent
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
International Standard
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
Influenza
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum
Influenza
10/226 Influenza Virus Infectious IVR-158
Influenza
10/232 Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent)
International Reference Reagent
10/234 Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent)
International Reference Reagent
10/236 Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent)
International Reference Reagent
10/238 Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent)
International Reference Reagent
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
International Standard
10/252 Factor VII Concentrate (2nd International Standard)
International Standard
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
Influenza
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
International Standard
10/266 4th WHO International Standard for HBV DNA for NAT
International Standard
10/272 BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent)
International Reference Reagent
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
International Standard
10/B596 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
Quality Control Reagent
100976 pCAGGS-SARS-CoV-2-Spike
NIBSC Repository - Research Use Only
100978 VeroE6/TMPRSS2
NIBSC Repository - Research Use Only
100980 SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020
NIBSC Repository - Research Use Only
100982 SARS-CoV-2 Nucleoprotein
NIBSC Repository - Research Use Only
100985 pCAGGS_SARS-CoV-2_Spike D614G
NIBSC Repository - Research Use Only
100986 pCAGGS-SARS-CoV-2-Spike Bristol Deletion
NIBSC Repository - Research Use Only
100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
NIBSC Repository - Research Use Only
100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
NIBSC Repository - Research Use Only
100989 pCRII-SARS-CoV-2 (5'UTR-NSP2)
NIBSC Repository - Research Use Only
100991 pCRII-SARS-CoV-2 (NSP4-NSP8)
NIBSC Repository - Research Use Only
100992 pCRII-SARS-CoV-2 (NSP4-NSP8)
NIBSC Repository - Research Use Only
100994 pCRII-SARS-CoV-2 (NSP15-NSP16)
NIBSC Repository - Research Use Only
100996 pCRII-SARS-CoV-2 (ORF3a-ORF6)
NIBSC Repository - Research Use Only
100998 SARS-CoV-2 infectious virus (CVR-GLA 1)
NIBSC Repository - Research Use Only
100999 SARS-CoV-2 infectious virus(CVR-GLA 2)
NIBSC Repository - Research Use Only
101000 SARS-CoV-2 infectious virus(CVR-GLA 3)
NIBSC Repository - Research Use Only
101001 VeroE6-ACE2
NIBSC Repository - Research Use Only
101003 VeroE6-ACE2-TMPRSS2
NIBSC Repository - Research Use Only
101004 A549-ACE2-TMPRSS2
NIBSC Repository - Research Use Only
101005 A549-ACE2 Clone8
NIBSC Repository - Research Use Only
101006 A549-ACE-2 Clone 8-TMPRSS2
NIBSC Repository - Research Use Only
101007 SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020
NIBSC Repository - Research Use Only
101008 HEK293T-ACE2-TMPRSS2
NIBSC Repository - Research Use Only
101009 Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)
NIBSC Repository - Research Use Only
101010 Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)
NIBSC Repository - Research Use Only
101011 Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC)
NIBSC Repository - Research Use Only
101019 VOC-202012/01 (B.1.1.7 lineage) lot 26012021
NIBSC Repository - Research Use Only
101022 SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4
NIBSC Repository - Research Use Only
101023 pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021
NIBSC Repository - Research Use Only
101024 pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021
NIBSC Repository - Research Use Only
101025 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2
NIBSC Repository - Research Use Only
101027 Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021
NIBSC Repository - Research Use Only
101029 SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021
NIBSC Repository - Research Use Only
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
Non WHO Reference Material
11/108 Influenza Virus infectious NYMC X-187
Influenza
11/126 Factors II and X Concentrate (4th International standard)
International Standard
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
Influenza
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
International Standard
11/176 (3rd International Standard) Low Molecular Weight Heparin
International Standard
11/184 High Molecular Weight Urokinase(2nd International Standard)
International Standard
11/206 Influenza anti-A/Perth/16/2009 HA Serum
Influenza
11/210 Anti-human CD4 FITC conjugated 0.5ml
Non WHO Reference Material
11/212 Biosynthetic Human Insulin (2nd WHO international Standard)
International Standard
11/214 Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent)
International Reference Reagent
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
International Standard
11/218 MLH1/MSH2 Exon Copy Number Reference Panel
European Certification
11/222 Influenza Virus Infectious NIB-79
Influenza
11/232 Influenza Virus Infectious B/Texas/6/2011
Influenza
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
International Standard
11/242 Viral Multiplex Reference
Non WHO Reference Material
11/244 Influenza Virus Infectiious NYMC BX-49
Influenza
11/B608 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
Quality Control Reagent
12/100 Influenza Virus Infectious NYMC X-217
Influenza
12/104 International Standard for IPV 12/104 (3rd International Standard)
International Standard
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
Influenza
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
Influenza
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
Influenza
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
Influenza
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
Influenza
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
Influenza
12/122 Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1)
Influenza
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
International Standard
12/176 Methylated Human Serum Albumin (mHSA)
Non WHO Reference Material
12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard)
International Standard
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
Influenza
12/202 Influenza virus infectious NYMC BX-39
Influenza
12/204 Influenza Virus infectious IVR-165
Influenza
12/208 Parvovirus B19 (3rd International Standard)
International Standard
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
International Reference Preparation
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
International Standard
12/244 Vi polysaccharide of C freundii WHO 1st International Standard
International Standard
12/252 ADAMTS 13 Plasma (1st International Standard)
International Standard
12/278 2nd Pneumococcal QC Serum Panel
International Standard
12/282 Diphtheria Toxin 1Lf/ml
Non WHO Reference Material
12/284 Anti-meningococcal serogroup Y monoclonal antibody
Non WHO Reference Material
12/290 Influenza Virus Infectious B/Brisbane/36/2012
Influenza
12/294 Influenza Virus Infectious NYMC BX-51C
Influenza
12/300 Negative Control IVIG (for use with IVIG and Anti-D)
Non WHO Reference Material
12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
International Standard
12/B611 Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1
Quality Control Reagent
12/B612 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
Quality Control Reagent
13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
International Standard
13/106 Influenza Antigen B/Massachusetts/02/2012
Influenza
13/108 Anti-Meningococcal serogroup B monoclonal antibody
Non WHO Reference Material
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
Influenza
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
Influenza
13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)
International Standard
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
Influenza
13/128 Influenza Virus Infectious NIBRG-269
Influenza
13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard).
International Standard
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
Influenza
13/146 C-Peptide, Human (1st International Standard).
International Standard
13/148 IVIG + anti-D for use with negative control IVIG
Non WHO Reference Material
13/152 Influenza Antigen B/Massachusetts/02/2012 (Cell Derived)
Influenza
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
Influenza
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
Influenza
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
Influenza
13/168 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
Clinical Virology Network
13/172 Lupus Anticoagulant (1st International Reference Panel)
International Reference Preparation
13/176 Influenza Virus Infectious NIBRG-88
Influenza
13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
Influenza
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
Influenza
13/200 Influenza Virus Infectious NIB-74
Influenza
13/202 Influenza Virus Infectious NIB-74xp
Influenza
13/204 TNF Rec II- FC Fusion protein (1st International Standard)
International Standard
13/206 Plasmin (4th International Standard)
International Standard
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
International Standard
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
International Reference Preparation
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
Non WHO Reference Material
13/218 Polio Anti Sabin type 1 (inactivated) Serum
Non WHO Reference Material
13/220 Polio Anti Sabin type 2 (inactivated) serum
Non WHO Reference Material
13/222 Polio Anti Sabin type 3 (inactivated) serum
Non WHO Reference Material
13/224 Influenza virus Infectious NIB-85. 36210 E5
Influenza
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
Influenza
13/234 Influenza antigen B/Brisbane/60/08
Influenza
13/238 Anti-EV71 serum LOW (WHO Reference Reagent)
International Reference Reagent
13/240 Tetanus Immunoglobulin, Human (2nd WHO International Standard)
International Standard
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
Working Standard
13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).
International Standard
13/248 Influenza virus infectious NIBRG-267 (H7N9)
Influenza
13/250 Influenza Virus Infectious NIBRG-268 (H7N9)
Influenza
13/252 Influenza virus infectious NYMC X-223A
Influenza
13/256 Influenza virus infectious. NYMC x-233
Influenza
13/258 Influenza virus infectious NYMC X-233A
Influenza
13/262 Meningococcal serogroup A polysaccharide
Non WHO Reference Material
13/264 Influenza Virus Infectious NYMC X-223
Influenza
13/B627 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
Quality Control Reagent
13/B629 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1
Quality Control Reagent
13/B634 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
Quality Control Reagent
13/B640 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5
Quality Control Reagent
13/B642 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
Quality Control Reagent
14/100 Human Papillomavirus (HPV) 11 DNA (1st International Standard)
International Standard
14/104 Human Papillomavirus (HPV) Type 45 DNA (1st International Standard)
International Standard
14/106 Influenza virus infectious. NYMC BX-51B
Influenza
14/114 JC Virus (JCV) DNA (1st International Standard)
International Standard
14/116 Influenza virus infectious NYMC X-179A
Influenza
14/118 Influenza virus infectious B/Massachusetts/2/2012
Influenza
14/140 1st International Standard for Anti EV71 Serum Human
International Standard
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)
Influenza
14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)
Influenza
14/148 Human Blood Factor IX Concentrate (5th International Standard).
International Standard
14/156 Meningococcal group X polysaccharide (1st WHO International Standard)
International Standard
14/160 High titre anti-A in IVIG working reference reagent
Working Standard
14/174 Botulinum Type A Antitoxin, Equine
Non WHO Reference Material
14/198 HBV,HCV,HIV Multiplex
Clinical Virology Network
14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)
Influenza
14/206 Influenza virus infectious NYMC X-247
Influenza
14/210 Biological activities of Rituximab WHO 1st International Standard
International Standard
14/212 BK Virus (BKV)(1st International Standard)
International Standard
14/224 Influenza virus infectious. A/Switzerland/9715293/2013
Influenza
14/226 Influenza Virus Infectious A/South Australia/55/2014
Influenza
14/228 Influenza Virus Infectious A/Stockholm/6/2014
Influenza
14/230 Influenza Virus Infectious. A/Norway/466/2014
Influenza
14/232 Influenza Virus Infectious IVR-175
Influenza
14/238 Recombinant Tissue factor
Working standard single unit sales
14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)
Influenza
14/256 Human Papillomavirus (HPV) Type 6 DNA (1st International Standard)
International Standard
14/258 Human Papillomavirus (HPV) Type 31 DNA (1st International Standard)
International Standard
14/260 Human Papillomavirus (HPV) Type 33 DNA (1st International Standard)
International Standard
14/262 Human Papillomavirus (HPV) Type 52 DNA (1st International Standard)
International Standard
14/264 Human Papillomavirus (HPV) Type 58 DNA (1st International Standard)
International Standard
14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)
Influenza
14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
Non WHO Reference Material
14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).
International Reference Reagent
14/306 Influenza Virus Infectious NYMC X-243 40180 E13
Influenza
14/308 Influenza Virus Infectious IVR-178 40200 E7
Influenza
14/314 Influenza Virus Infectious NIB-88
Influenza
14/316 Factor IX activated (FIXa) 2nd WHO International Standard
International Standard
14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)
Influenza
14/320 Influenza Virus Infectious B/Utah/9/2014
Influenza
14/322 Influenza Virus Infectious NIB-91
Influenza
14/B651 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2
Quality Control Reagent
14/B653 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
Quality Control Reagent
14/B654 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1
Quality Control Reagent
14/B655 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
Quality Control Reagent
15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)
Influenza
15/102 Activated Blood Coagulation Factor X (FXa), Human
International Reference Reagent
15/104 Influenza Antigen A/South Australia/55/2014 Cell derived
Influenza
15/106 Ancrod
International Standard
15/126 Bordetella pertussis toxin (20µg). (2nd International Standard)
International Standard
15/130 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)
Clinical Virology Network
15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum
Influenza
15/136 EBOV RNA NP-VP35-GP in-run control
International Reference Reagent
15/138 EBOV RNA VP40-L in-run control
International Reference Reagent
15/140 Batroxobin
International Reference Reagent
15/148 Influenza Virus Infectious NIB-92
Influenza
15/154 Influenza Virus Infectious NIB-93
Influenza
15/158 Influenza Virus Infectious NYMC X-263
Influenza
15/160 Influenza Virus Infectious NIBRG-306
Influenza
15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent
International Reference Reagent
15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)
International Standard
15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate
Working Standard
15/184 Influenza Virus Infectious NYMC X-263B
Influenza
15/188 Influenza Virus Infectious NYMC X-263A
Influenza
15/194 Influenza Virus Infectious NYMC X-257A
Influenza
15/196 Influenza Virus Infectious NYMC X-261
Influenza
15/212 Influenza Virus Infectious NYMC BX-53C
Influenza
15/220 Anti-EBOV plasma, human (WHO Reference Reagent)
International Reference Reagent
15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)
International Reference Reagent
15/224 EBOV RNA VP40-L (WHO Reference Reagent)
International Reference Reagent
15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7
Influenza
15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)
Influenza
15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)
International Standard
15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)
International Standard
15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)
Influenza
15/250 Influenza Virus Infectious NYMC BX-31
Influenza
15/252 Influenza Virus Infectious A/California/7/2009
Influenza
15/262 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool
International Standard
15/266 HHV-6 Virus 1st WHO International Standard
International Standard
15/270 CD4 WHO Reference Reagent
International Reference Reagent
15/272 ICS Positive Control-Lymphocytes
Non WHO Reference Material
15/274 Influenza Virus Infectious NYMC BX-59A
Influenza
15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)
International Standard
15/294 Influenza virus infectious NYMC BX-59B
Influenza
15/296 Sabin monovalent Polio vaccine type 2 (1st International Standard)
International Standard
15/298 Influenza Virus Infectious B/Brisbane/46/2015
Influenza
15/300 Influenza Virus Infectious NYMC BX-35 41950 E11
Influenza
15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard
International Standard
15/B658 QCRLYMEQC1 - Anti-Lyme QC1
Quality Control Reagent
15/B664 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1
Quality Control Reagent
15/B667 QCRMEASQC1 Anti-Measles QC1
Quality Control Reagent
15/B671 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
Quality Control Reagent
15/B678 QCRPARVB19QC1 Anti-Parvovirus B19QC1
Quality Control Reagent
15/B680 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
Quality Control Reagent
16/104 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques
Clinical Virology Network
16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)
Influenza
16/108 Influenza Virus Infectious A/PR/8/34
Influenza
16/110 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)
Non WHO Reference Material
16/114 Influenza anti - A/California/7/09 HA serum
Influenza
16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)
Influenza
16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F
International Standard
16/126 Native Vi polysaccharide (S. Typhi)
International Standard
16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard
International Standard
16/152 Meningococcal Serogroup W Polysaccharide
International Standard
16/164 Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard)
International Standard
16/170 Infliximab (1st International Standard)
International Standard
16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum
Influenza
16/190 Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent)
International Reference Reagent
16/192 Influenza Anti - B/Brisbane/60/2008-HA serum
Influenza
16/194 HIV-1 RNA (4th International Standard)
International Standard
16/196 Sabin monovalent Polio vaccine type 1(1st International Standard)
International Standard
16/200 Influenza Virus Infectious NIB-58
Influenza
16/202 OPV reference mOPV 3
International Standard
16/204 7th WHO International Standard for Rabies Vaccine
International Standard
16/206 Meningococcal serogroup Y Polysaccharide
International Standard
16/208 Influenza Virus Infectious NIB-97 42090 E7
Influenza
16/210 HIV-1 P24 Antigen (1st international reference panel)
International Standard
16/236 HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent)
International Reference Reagent
16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)
Influenza
16/242 Influenza Virus Infectious NIB-98 42110 E7
Influenza
16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations
International Standard
16/268 Influenza Virus Infectious X-273
Influenza
16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1
Influenza
16/274 Influenza Virus Infectious X-275A 42010 E13
Influenza
16/278 Anti-D Immunglobulin control preparation
Working Standard
16/282 Influenza Virus Infectious X-285 42430 ExE1
Influenza
16/284 Antiserum to Respiratory Syncytial Virus WHO 1st International Standard
International Standard
16/286 Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)
Influenza
16/288 Influenza Virus Infectious X-283A 42420 ExE1
Influenza
16/290 Influenza Virus Infectious X-285A 42440 ExE1
Influenza
16/292 Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)
Influenza
16/296 Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard)
International Standard
16/302 Tetanus Toxoid for use in Flocculation Test (3rd International Standard)
International Standard
16/320 Zika Antibody Working reagent
Working standard single unit sales
16/324 Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard).
International Standard
16/332 Anti-D Immunoglobulin (Replacement IS)
International Standard
16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel)
International Reference Preparation
16/352 Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)
International Standard
16/358 Streptokinase (4th WHO International Standard)
International Standard
16/360 Influenza Virus Infectious NIB-96 41920 E7
Influenza
16/362 Influenza Virus Infectious NYMC X-291 42530 E8
Influenza
16/364 3rd International Standard for Prekallikrein Activator
International Standard
16/366 Influenza Virus Infectious NYMC X-291A 42540 E8
Influenza
16/368 HSV-1
International Standard
16/374 Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard)
International Standard
16/376 Plasmodium falciparum antigens (1st International Standard)
International Standard
16/B685 QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2
Quality Control Reagent
16/B693 QCRCMVIgMQC1 IgM Anti-CMV QC1
Quality Control Reagent
16/B695 QCRTOXOIgMQC1 IgM Anti-Toxoplasma gondii QC1
Quality Control Reagent
16/B697 QCREBVVCAQC1
Quality Control Reagent
16/B704 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
Quality Control Reagent
16/B707 QCREBVNEGQC1
Quality Control Reagent
17/100 Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)
International Standard
17/102 Prostate Specific Antigen (human) (Free), (2nd WHO International Standard)
International Standard
17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum
Influenza
17/122 HSV-2
International Standard
17/124 Influenza Virus Infectious NYMC BX-63 42790 E10/E1
Influenza
17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1
Influenza
17/132 Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637)
Influenza
17/136 Influenza Virus Infectious NIBRG-375 (H7N9)
Influenza
17/142 Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1)
Influenza
17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
Influenza
17/156 Influenza Virus Infectious CNIC-1701 42910 E9
Influenza
17/160 Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard)
International Standard
17/162 Influenza Virus Infectious NYMC X-299 42920 E10
Influenza
17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5
Influenza
17/182 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
Influenza
17/184 Influenza Virus Infectious NIB-103 42610 E7
Influenza
17/190 Influenza Virus Infectious NYMC X-297 42940 E11
Influenza
17/194 Influenza Virus Infectious NIB-104
Influenza
17/204 1st International Standard for Darbepoetin
International Standard
17/206 14th British Standard for Coagulation Factor VIII Concentrate, Human.
Working Standard
17/210 Influenza Virus Infectious IVR-186 43310 E8
Influenza
17/212 Anti-HLA Negative Control for FCXM and bead- based assays
European Certification
17/232 Tumor Necrosis Factor alpha (human rDNA derived)
Working standard single unit sales
17/236 Adalimumab (1st WHO International Standard)
International Standard
17/238 Anti-HLA Positive Control for FCXM and bead-based assays
European Certification
17/240 5% Immunoglobulin (Negative Control)
Non WHO Reference Material
17/246 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)
Influenza
17/252 Influenza Virus Infectious NYMC BX-69 43220 E13
Influenza
17/256 Influenza Virus Infectious NYMC BX-69A
Influenza
17/258 Influenza Virus Infectious B/Alabama/2/2017
Influenza
17/264 Influenza Virus Infectious A/Michigan/45/2015 43470 E5
Influenza
17/B710 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1
Quality Control Reagent
17/B713 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2
Quality Control Reagent
17/B717 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
Quality Control Reagent
17/B723 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1
Quality Control Reagent
17/B725 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
Quality Control Reagent
17/B728 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1
Quality Control Reagent
18/100 Influenza Antigen B/Maryland/15/2016
Influenza
18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)
Influenza
18/108 Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum
Influenza
18/110 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186)
Influenza
18/112 Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum
Influenza
18/116 WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4)
International Standard
18/118 1st International Standard for HCT 15 Cancer Genome
International Standard
18/120 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4)
International Reference Reagent
18/130 1st International Standard for MOLT-4 Cancer Genome
International Standard
18/134 Influenza Virus Infectious NIBRG-301 (H5N1)
Influenza
18/136 Influenza Virus Infectious NIBRG-14 (H5N1)
Influenza
18/138 Influenza Virus Infectious NYMC X-307A
Influenza
18/140 Influenza Virus Infectious NYMC X-307
Influenza
18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis
International Standard
18/146 Pertussis antiserum (human) panel
Non WHO Reference Material
18/154 Bordetella pertussis, pertactin, PRN
Non WHO Reference Material
18/156 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4)
International Reference Reagent
18/160 Influenza Virus Infectious NYMC X-311
Influenza
18/164 1st International Standard for ATDB102 Genome
International Standard
18/166 Influenza Virus Infectious NIB-112 43990 E6
Influenza
18/168 Influenza Virus Infectious A/Switzerland/8060/2017
Influenza
18/170 Influenza anti-B/Colorado/06/2017-like HA serum
Influenza
18/174 Influenza Virus Infectious A/Brisbane/1/2018
Influenza
18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)
International Standard
18/188 Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112)
Influenza
18/190 Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311)
Influenza
18/192 Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum
Influenza
18/194 Influenza Virus Infectious NYMC X-275 (Influenza Reagent)
Influenza
18/196 Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9)
Influenza
18/206 West Nile Virus - International Standard
International Standard
18/208 WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays
International Reference Reagent
18/210 Bevacizumab (1st WHO International Standard)
International Standard
18/220 Anti-HPA 15b minimum potency reagent (WHO Reference Reagent)
International Reference Reagent
18/226 Influenza Virus Infectious IVR-190 44250 E12
Influenza
18/230 Influenza Virus Infectious B/Colorado/06/2017 43460 E7
Influenza
18/234 Influenza Virus Infectious NIB116-B 44230 E5
Influenza
18/236 Influenza Virus Infectious A/Brisbane/02/2018
Influenza
18/238 Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1)
Influenza
18/240 Influenza Virus Infectious NYMC X-327 44280 E17
Influenza
18/242 Influenza Virus Infectious A/Kansas/14/2017 43880 E8
Influenza
18/244 Human Chorionic Gonadotropin (hCG) (6th International Standard)
International Standard
18/B731 Anti CMV QC1 QCRCMVQC1
Quality Control Reagent
18/B732 QCRNEGQC1-Negative Quality Control Serum: Sample1
Quality Control Reagent
18/B733 QCREBVIgMQC1
Quality Control Reagent
18/B742 QCRLYMEIgMQC1 IgM Anti-Lyme QC1
Quality Control Reagent
19/102 Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701)
Influenza
19/104 Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2)
Influenza
19/106 Influenza Virus Infectious IVR-195 44300 E9
Influenza
19/108 Trastuzumab (1st WHO international Standard)
International Standard
19/112 Influenza Virus Infectious NIB-110
Influenza
19/116 1st WHO Plasmodium Vivax Antigen (LDH)
International Standard
19/120 Influenza Virus Infectious X-327 A 44310 E18
Influenza
19/146 Influenza Virus Infectious CNIC-1903
Influenza
19/148 Influenza Virus Infectious CNIC-1902 44320 E10
Influenza
19/152 Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum
Influenza
19/154 Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2)
Influenza
19/156 Panel of recombinant antibody controls for Cytokine Release Assays
Working standard single unit sales
19/160 Influenza Virus Infectious A/California/7/09 44430 E6
Influenza
19/166 Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)
International Standard
19/172 Influenza Virus Infectious BVR-11
Influenza
19/174 Influenza Virus Infectious IVR-197 (H3N2) 44850 E14
Influenza
19/176 Influenza Virus Infectious B/Victoria/705/2018
Influenza
19/178 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human)
International Standard
19/180 Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody
Non WHO Reference Material
19/188 3rd International Standard Thrombin
International Standard
19/192 Influenza Virus Infectious IVR-202 (H3N2) 44880 E10
Influenza
19/194 Influenza Virus Infectious B/Brisbane/35/2018
Influenza
19/198 1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma
International Reference Reagent
19/204 Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived)
Influenza
19/206 Influenza Virus Infectious X-181 45030 E8
Influenza
19/208 Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage)
Influenza
19/210 Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived)
Influenza
19/212 Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2)
Influenza
19/216 Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716)
Influenza
19/224 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11
International Standard
19/226 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58
International Standard
19/228 Influenza Virus Infectious A/South Australia/34/2019
Influenza
19/230 Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4
Influenza
19/236 Diphtheria Antitoxin Equine (DI)
International Standard
19/238 Influenza Antigen B/Washington/02/2019 9B Victoria Lineage)
Influenza
19/240 British Working Standard for Anti-HCV
European Certification
19/242 British Working Standard for Anti HCV 1 in 8 Dilution
European Certification
19/256 Influenza Virus Infectious BX-85C 45230 E13
Influenza
19/258 Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1
Influenza
19/262 Influenza Virus Infectious CNIC-1909 (H1N1) 45290 E2/E8/E1
Influenza
19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5
Influenza
19/294 Influenza Virus Infectious A/Guangdong-Maonan/SWL1536/2019 (H1N1) 44760 E3/E1
Influenza
19/304 Research reagent for SARS-CoV-2 RNA
Non WHO Reference Material
19/306 Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1)
Influenza
19/308 Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived)
Influenza
19/314 Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728)
Influenza
19/316 Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734)
Influenza
19/318 Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742)
Influenza
19/320 Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736)
Influenza
19/322 Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748)
Influenza
19/B747 QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4
Quality Control Reagent
19/B751 QCREBNAQC1
Quality Control Reagent
19/B753 QCREBVEAQC1
Quality Control Reagent
19/B754 Anti-Rubella QC2
Quality Control Reagent
20/102 Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1
Influenza
20/104 Influenza Virus Infectious IVR-208 (H3N2) 45330 E7/E10/E1
Influenza
20/106 Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1
Influenza
20/108 Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2)
Influenza
20/110 SARS-CoV-2 (NAT)
Clinical Virology Network
20/112 IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2
Non WHO Reference Material
20/132 Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2)
Influenza
20/134 Influenza Virus Infectious BX-57 45430 E4/E10/E1
Influenza
20/138 Working Reagent for SARS-CoV-2 RNA
Non WHO Reference Material
20/146 First WHO International Standard for SARS-CoV-2 RNA
International Standard
20/162 NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant
Quality Control Reagent
20/164 Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1
Influenza
20/170 NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT)
Clinical Virology Network
20/180 Influenza A (H1N1) Panel
Non WHO Reference Material
20/182 Influenza A (H3N2) Panel
Non WHO Reference Material
20/184 Influenza B Panel
Non WHO Reference Material
20/186 RSV A Panel
Non WHO Reference Material
20/188 RSV B Panel
Non WHO Reference Material
20/190 SARS-CoV-2 Panel
Non WHO Reference Material
20/212 Influenza virus infectious IVR-215 (H1N1) 45620 E4/D7/E1
Influenza
20/214 Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1
Influenza
20/216 Influenza virus Infectious A/Victoria/2570/2019 (H1N1) 45380 E5
Influenza
20/220 Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1
Influenza
20/232 Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1)
Influenza
20/234 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754)
Influenza
20/236 Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720
Influenza
20/238 Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730
Influenza
20/242 Influenza Virus Infectious B/Washington/02/2019 E4 44600
Influenza
20/264 Influenza Virus Infectious X-341 + 1P (H3N2)
Influenza
20/266 Nucleic Acid Amplification Technique (NAT) Panel for SARS-CoV-2
Clinical Virology Network
20/268 1st International Reference Panel for Anti-SARS-CoV-2 Immunoglobulin
International Reference Preparation
20/294 Influenza Virus Infectious X-347 (H3N2)
Influenza
20/296 Influenza Virus Infectious X-347A (H3N2)
Influenza
20/310 Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2)
Influenza
20/318 Influenza Virus Infectious IVR-221 (H3N2)
Influenza
20/322 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2)
Influenza
20/B758 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
Quality Control Reagent
20/B764 QCRSARSCoV2QC1
Quality Control Reagent
20/B767 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
Quality Control Reagent
20/B770 Anti-SARS-CoV-2 Verification Panel for Serology Assays
Quality Control Reagent
20/B774 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1
Quality Control Reagent
21/100 Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2)
Influenza
21/116 Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2)
Influenza
21/118 Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum
Influenza
21/122 Influenza Virus Infectious X-357A (H3N2)
Influenza
21/124 Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage)
Influenza
21/130 Influenza Virus Infectious SAN-004A (H3N2)
Influenza
21/132 Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage)
Influenza
21/136 Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage)
Influenza
21/148 Influenza Virus Infectious X-359 (H3N2)
Influenza
21/150 Influenza Virus Infectious X-359A (H3N2)
Influenza
21/156 Influenza Virus Infectious BX-93A (B-Victoria Lineage)
Influenza
21/158 Influenza Virus Infectious BX-93B (B-Victoria Lineage)
Influenza
21/160 Influenza Virus Infectious X-353 (H3N2)
Influenza
21/164 Influenza Virus Infectious X-355B (H3N2)
Influenza
21/166 Influenza Virus Infectious X-355A-CL (H3N2)
Influenza
21/180 Meningococcal Capsular Group W polysaccharide
Non WHO Reference Material
21/186 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)
Influenza
21/190 Influenza Virus Infectious X-361A (H3N2)
Influenza
21/192 Influenza Virus Infectious BX-97A (B-Victoria Lineage)
Influenza
21/194 Influenza Virus Infectious A/Hong Kong/2671/2019
Influenza
21/196 Influenza Virus Infectious IVR-224 (H3N2)
Influenza
21/204 Influenza Virus Infectious IVR-227 (H3N2)
Influenza
21/234 Working reagent for anti-SARS-CoV-2 immunoglobulin
Non WHO Reference Material
21/B777 Ferritin Quality Control Sample
Quality Control Reagent
234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)
Non WHO Reference Material
2BADS Anti-Brucella Abortus Serum, Bovine (International Standard)
International Standard
2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard)
International Standard
2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)
International Standard
4024 Antisera to SARS CoV-1 S1 Protein (Rabbit)
NIBSC Repository - Research Use Only
520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)
Non WHO Reference Material
59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine
Non WHO Reference Material
59/016 Corticotrophin (ACTH), Porcine (3rd International Standard)
International Standard
59/021 Botulinum Antitoxin Equine Type A
Non WHO Reference Material
60/001 Botulinum Antitoxin Equine Type B
Non WHO Reference Material
60/013 Tetanus Antitoxin, Equine, for Bioassay
Non WHO Reference Material
62/014 Lysine Vasopressin, Porcine
Non WHO Reference Material
63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine
Non WHO Reference Material
64/002 Rheumatoid Arthritis Serum
Non WHO Reference Material
64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine
Non WHO Reference Material
64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine
Non WHO Reference Material
65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent)
International Reference Reagent
65/119 Renin, Porcine
Non WHO Reference Material
65/122 Long-acting Thyroid Stimulator, Human
Non WHO Reference Material
66/021 Tetanus Antitoxin, Equine, for Flocculation Test
Non WHO Reference Material
66/138 Gastrin II, Porcine
Non WHO Reference Material
66/153 Diphtheria Antitoxin, Equine
Non WHO Reference Material
66/233 Anti-Nuclear Factor Serum (Homogenous) Human
Non WHO Reference Material
67/037 Immunoglobulin D (IgD) Serum, Human
Non WHO Reference Material
67/086 Immunoglobulins G, A, M Serum Human (International Standard)
International Standard
67/099 Immunoglobulins G, A & M Serum Human
Non WHO Reference Material
67/182 Anti-Rubella Serum, Human
European Certification
67/183 Primary Biliary Cirrhosis Serum, Human
Non WHO Reference Material
68/340 Anti-Nucleolar Factor Plasma, Human
Non WHO Reference Material
68/356 Renin, Human (International Standard)
International Standard
69/065 Autoimmune Antibody to Human Spermatazoa
Non WHO Reference Material
69/194 Glucagon, Porcine (First International Standard)
International Standard
70/302 Angiotensin II (25µg)
Non WHO Reference Material
71/281 Anti-Malaria Plasma P Vivax
Non WHO Reference Material
71/326 Anti-Malaria Plasma Vivax Ng2
Non WHO Reference Material
72/092 Anti-malaria Plasma: Plasmodium falciparum (Ghana)
Non WHO Reference Material
72/096 Anti-Malaria Serum (P.Malariae)
Non WHO Reference Material
72/341 Anti-Malaria Plasma P Falciparum
Non WHO Reference Material
72/345 Anti-Malaria Plasma P Falciparum
Non WHO Reference Material
72/348 Anti-Malaria Plasma P Vivax
Non WHO Reference Material
73/517 Anti-D (Rho) Antibodies, Human
European Certification
73/545 Placental Lactogen, Human (International Reference Preparation)
International Standard
73/554 Cholera Vaccine (Inaba)
Non WHO Reference Material
73/556 Cholera Vaccine (Ogawa)
Non WHO Reference Material
73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
International Standard
74/520 Serum Proteins (Other than Immunoglobulins) Human
Non WHO Reference Material
74/581 Ancrod (1st International Reference Preparation)
International Standard
74/586 Corticotrophin (ACTH), Porcine (International Working Standard)
International Standard
75/506 Cocksfoot Pollen Extract
Non WHO Reference Material
75/533 Chorionic Gonadotrophin, Human, for Radioiodination
Non WHO Reference Material
75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination
Non WHO Reference Material
75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)
International Reference Preparation
75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)
International Reference Preparation
75/595 Blood Coagulation Factor Xa, Bovine
Non WHO Reference Material
76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination
Non WHO Reference Material
76/515 Mannan (Candida Albicans) Purified
Non WHO Reference Material
76/522 Opacity 5IRP WHO International Standard
International Standard
76/525 Anti-Birch Pollen Serum, Human
Non WHO Reference Material
76/547 Influenza anti A/Victoria/3/75 Serum(goat)
Influenza
76/575 Oxytocin(4th International Standard)
International Standard
77/503 Anti-Cocksfoot Serum, Human
Non WHO Reference Material
77/512 Lysine Vasopressin(1st International Standard)
International Standard
77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum
Influenza
77/568 Influenza anti B/Hong Kong/8/73 Serum
Influenza
77/584 Anti-D Pteronyssinus Serum, Human
Non WHO Reference Material
77/600 Mannan (Candida Albicans) Purified
Non WHO Reference Material
77/616 Twelve Grass Pollen Extract
Non WHO Reference Material
77/643 Secretin
Non WHO Reference Material
77/662 Acarus Siro Extract
Non WHO Reference Material
77/664 Glycyphagus destructor Extract
Non WHO Reference Material
78/517 Tyrophagus Putrescentiae Extract
Non WHO Reference Material
78/543 Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)
International Standard
78/545 Anti-Aspergillus fumigatus Serum, Human
Non WHO Reference Material
78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard)
International Standard
78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard)
International Standard
78/560 Influenza Antigen A/Texas/1/77
Influenza
78/569 Influenza anti A/Texas/1/77 Serum
Influenza
78/575 Aspergillus Fumigatus Extract
Non WHO Reference Material
78/582 Tyrophagus Longior Extract
Non WHO Reference Material
78/628 Bee Venom
Non WHO Reference Material
79/500 Parathyroid Hormone, HumanRef. Preparation)
International Reference Preparation
79/516 Influenza anti A/Brazil/11/78 Serum (goat)
Influenza
79/552 Influenza Antigen A/USSR/92/77
Influenza
79/558 Influenza Antigen A/USSR/92/77
Influenza
79/560 Influenza Antigen A/Brazil/11/78
Influenza
79/568 Influenza Antigen B/Hong Kong/8/73
Influenza
79/572 Prekallikrein Activator (PKA), Human
Non WHO Reference Material
80/505 Growth Hormone, Human, Pituitary. WHO International Standard
International Standard
80/517 Influenza Antigen A/Bangkok/1/79
Influenza
80/519 Influenza Antigen B/Singapore/222/79
Influenza
80/523 Influenza anti B/Singapore/222/79 Serum
Influenza
80/525 Influenza anti A/Bangkok/1/79 Serum
Influenza
80/590 Tetracosactide. International Ref. Preparation
International Reference Preparation
81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard)
International Standard
81/565 Thyroid Stimulating Hormone, Human. WHO International Standard
International Standard
82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment
Non WHO Reference Material
82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment
Non WHO Reference Material
82/518 Dermatophagoides Pteronyssinus Extract. WHO International Standard
International Standard
82/520 Timothy Pollen Extract. WHO International Standard
International Standard
82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)
International Standard
82/587 Interferon Gamma (Human, Leukocyte derived)
Non WHO Reference Material
82/632 Parathyroid Hormone, Bovine. WHO International Standard
International Standard
82/652 Human Serum Vitamin B12, Pernicous anaemia
Non WHO Reference Material
83/501 Beta Thromboglobulin, Purified Human. WHO International Standard
International Standard
83/505 Platelet Factor 4 Human, Purified. WHO International Standard
International Standard
83/511 Insulin, Bovine. WHO International Standard
International Standard
83/514 Interferon alpha-1D, (Human rDNA derived) WHO International Standard
International Standard
83/515 Insulin, Porcine. WHO International Standard
International Standard
83/537 Influenza Antigen A/Philippines/2/82
Influenza
83/545 Influenza anti A/Philippine/2/82 Serum
Influenza
83/550 Influenza Antigen A/Brazil/11/78
Influenza
83/573 Prolactin, Human (4th WHO International Standard.)
International Standard
83/575 Follicle Stimulating Hormone, Pituitary. WHO International Standard
International Standard
84/514 Proinsulin, Bovine. International Ref. Preparation
International Reference Preparation
84/522 Birch Pollen Extract. WHO International Standard
International Standard
84/528 Proinsulin, Porcine. International Ref. Reagent
International Reference Reagent
84/538 Influenza Antigen A/Chile/1/83
Influenza
84/542 Influenza Antigen B/Norway/1/84
Influenza
84/581 Short Ragweed Pollen Extract. WHO International Standard
International Standard
84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard
International Standard
84/628 Anti-c Serum, Human
European Certification
84/636 Influenza anti B/USSR/100/83 Serum
Influenza
84/640 Influenza anti A/Chile/1/8 Serum
Influenza
84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)
Influenza
84/685 Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard
International Standard
85/506 C-Reactive Protein, Human. WHO International Standard
International Standard
85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum
Influenza
85/520 Influenza Antigen A/Equine/Kentucky/1/81
Influenza
85/522 Thyroid Stimulating Hormone beta subunit
Non WHO Reference Material
85/551 Anti-Rye Grass Serum, Human
Non WHO Reference Material
85/616 Haemoglobin F Lysate, Raised. WHO Reference Reagent
International Reference Reagent
85/669 Atrial Natriuretic Factor, Human. WHO International Standard
International Standard
86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard)
International Standard
86/536 Angiotensin I Human Type Synthetic
Non WHO Reference Material
86/538 Angiotensin II (2.5µg)
Non WHO Reference Material
86/552 Interleukin-1 Beta (Human, rDNA derived)
Non WHO Reference Material
86/576 Influenza Antigen A/Mississippi/1/85
Influenza
86/590 Influenza anti A/Mississippi/1/85 Serum
Influenza
86/592 Influenza anti B/Ann Arbor/1/86/HA Serum
Influenza
86/630 Influenza Antigen B/Ann Arbor/ 1/86
Influenza
86/632 Interleukin-1 alpha (Human rDNA derived) WHO International Standard
International Standard
86/678 Interleukin-1 alpha (Human, rDNA derived)
Non WHO Reference Material
86/680 Interleukin-1 beta (Human, rDNA derived) WHO International Standard
International Standard
86/690 Inhibin, Porcine WHO International Standard
International Standard
87/510 Influenza Antigen A/Equine/Miami/63
Influenza
87/578 Influenza anti A/Leningrad/360/86 Serum
Influenza
87/584 Influenza Antigen A/Leningrad/360/86
Influenza
87/586 Interferon Gamma (Human, rDNA derived)
Non WHO Reference Material
87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
87/654 Anti-Ferritin Monoclonal Antibody (1)
Non WHO Reference Material
87/662 Anti-Ferritin Monoclonal Antibody (2)
Non WHO Reference Material
87/714 Influenza Antigen A/Sichuan/2/87
Influenza
87/774 Influenza Antigen B/Victoria/2/87
Influenza
88/522 Bordetella pertussis (Whole cell vaccine) 3BRP
Non WHO Reference Material
88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived)
Non WHO Reference Material
88/554 Influenza Antigen B/Beijing/1/87
Influenza
88/556 Calcitonin, Eel WHO International Standard
International Standard
88/638 Thyroxine-binding globulin. WHO International Standard
International Standard
88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
International Standard
88/654 Influenza Antigen A/England/427/88
Influenza
88/656 Interleukin-4 (Human, rDNA derived) WHO International Standard
International Standard
88/672 Influenza anti A/Sichuan/2/87 Serum
Influenza
88/678 Influenza anti B/Beijing/1/87 Serum
Influenza
88/846 Influenza anti A/England/427/88 Serum
Influenza
89/512 Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard
International Standard
89/514 Transforming Growth Factor beta-1 (Human, rDNA derived)
Non WHO Reference Material
89/516 Transforming Growth Factor beta-1 (Bovine)
Non WHO Reference Material
89/518 Transforming Growth Factor beta-2 (Bovine)
Non WHO Reference Material
89/520 Interleukin-8 (Human, rDNA derived) WHO International Standard
International Standard
89/530 Anti-Bordetella pertussis serum (Human)
Non WHO Reference Material
89/544 Renin, Human, rec DNA
Non WHO Reference Material
89/548 Interleukin-6 (Human, rDNA derived) WHO International Standard
International Standard
89/568 Influenza Antigen A/OMS/5389/88
Influenza
89/594 Bordetella pertussis (W28) LPS 2ug
Non WHO Reference Material
89/596 Bordetella pertussis anti-agglutinogen 1(rabbit)
Non WHO Reference Material
89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit)
Non WHO Reference Material
89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit)
Non WHO Reference Material
89/620 Calcitonin, Human. WHO International Standard
International Standard
89/666 Haemoglobin A2 Lysate, Raised. WHO Reference Reagent
International Reference Reagent
89/670 Bordetella pertussis (W28) LPS25ug
Non WHO Reference Material
90/500 Influenza Antigen A/Shanghai/16/89
Influenza
90/502 Influenza Antigen A/Guizhou/54/89
Influenza
90/504 Influenza anti A/Guangdong/39/89 Serum
Influenza
90/520 Bordetella pertussis, filamentous haemagglutinin (FHA)
Non WHO Reference Material
90/530 Interleukin-7 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
90/534 Mumps Vaccine (Live) WHO Reference Reagent
International Reference Reagent
90/586 Interleukin-5 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
90/636 HIV-1 P24 Antigen WHO International Standard
International Standard
90/690 Anti-Varicella-Zoster Antibody
European Certification
90/696 Transforming Growth Factor beta-2, Human, rec DNA
Non WHO Reference Material
90/712 Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard
International Standard
90/784 Influenza Virus infectious NIB-26 (H3N2)
Influenza
91/510 Interleukin-3 (Human, rDNA derived) WHO International Standard
International Standard
91/530 Epidermal Growth Factor (Human, rDNA derived) WHO International Standard
International Standard
91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
91/554 Insulin-like growth Factor 1 WHO International Standard
International Standard
91/612 Influenza anti A/Taiwan/1/86 Serum
Influenza
91/624 Recombinant Human Inhibin
International Standard
91/626 Activin A, Human, Recombinant. WHO Reference Reagent
International Reference Reagent
91/656 Interleukin-4 (Mouse, rDNA derived)
Non WHO Reference Material
91/658 Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)
Non WHO Reference Material
91/662 Interleukin-3 (Mouse, rDNA derived)
Non WHO Reference Material
91/670 Influenza Virus infectious NIB-27 (H1N1)
Influenza
91/678 Interleukin-9 (Human,rDNA derived) WHO Reference Reagent
International Reference Reagent
91/682 Stem Cell Factor (Human rDNA derived) WHO Reference Reagent
International Reference Reagent
91/688 Rubella Vaccine (Live) 1st International Reference Reagent
International Standard
92/510 Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard)
International Standard
92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard
International Standard
92/518 Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)
Non WHO Reference Material
92/520 Rantes (Human, rDNA derived)
Non WHO Reference Material
92/530 Influenza Antigen A/Texas/36/91
Influenza
92/582 Influenza anti B/Yamagata/16/88 Serum
Influenza
92/628 Influenza Antigen B/Yamagata/16/88
Influenza
92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum
Influenza
92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)
Non WHO Reference Material
92/648 Measles Vaccine (Live) 2nd International Reference Reagent
International Standard
92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard
International Standard
92/658 Papain preparation for use with Anti-D preparation 91/562
Working Standard
92/680 Serum amyloid A protein. WHO International Standard
International Standard
92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2)
Influenza
92/738 Influenza Virus infectious A/Shanghai/24/90
Influenza
92/788 Interleukin-11 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived)
Non WHO Reference Material
93/500 Influenza Antigen A/Beijing/32/92
Influenza
93/516 Influenza Antigen A/Shanghai/24/90
Influenza
93/518 Influenza anti A/Beijing/32/92 (H3N2) Serum
Influenza
93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum
Influenza
93/556 Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
93/560 Insulin-like growth Factor Binding Protein-3
Non WHO Reference Material
93/562 Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
93/564 Oncostatin M (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
93/566 Interleukin-2 (Mouse, rDNA derived)
Non WHO Reference Material
93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2)
Influenza
93/574 Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
93/668 Interleukin-1 beta (Mouse, rDNA derived)
Non WHO Reference Material
93/672 Interleukin-1 alpha (Mouse, rDNA derived)
Non WHO Reference Material
93/692 Influenza Virus infectious B/Panama/45/90
Influenza
93/722 Interleukin-10 (Human rDNA derived) WHO Reference Reagent
International Reference Reagent
93/730 Interleukin-6 (Mouse, rDNA derived)
Non WHO Reference Material
93/740 Interleukin-7 (Mouse, rDNA derived)
Non WHO Reference Material
93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2)
Influenza
94/500 Influenza Antigen B/Panama/45/90
Influenza
94/504 Influenza anti A/Shanghai/9/93 Serum
Influenza
94/516 Influenza Antigen A/Shangdong/9/93
Influenza
94/520 Influenza anti B/Panama/45/90 Serum
Influenza
94/532 Pertussis Vaccine (Whole Cell) WHO International Standard
International Standard
94/572 Ferritin, Human, recombinant. WHO International Standard
International Standard
94/622 Interleukin-13 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
94/674 Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent
International Reference Reagent
94/684 Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
94/718 Staphylokinase, rec (STAR)
Non WHO Reference Material
94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard
International Standard
94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard
International Standard
94/754 Interferon Omega (Human, rDNA derived) WHO International Standard
International Standard
94/762 Influenza Virus infectious RESVIR-8 (H3N2)
Influenza
94/766 Influenza Virus infectious NIB-34 (H3N2)
Influenza
94/784 Interferon alpha (Human, leukocyte derived)WHO International Standard
International Standard
94/786 Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard
International Standard
94/790 MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard
International Standard
95/510 Influenza Antigen A/Texas/36/91
Influenza
95/516 Influenza Antigen A/Johannesburg/33/94
Influenza
95/522 Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard
International Standard
95/524 Influenza anti A/Johannesburg/33/94 Serum
Influenza
95/528 Folate, Whole Blood Haemolysate WHO International Standard
International Standard
95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard
International Standard
95/544 Interleukin-12 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
95/554 Interleukin-15 (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)
Non WHO Reference Material
95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard
International Standard
95/572 Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard
International Standard
95/574 Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard
International Standard
95/580 Interferon alpha-2c (Human, rDNA derived) WHO International Standard
International Standard
95/646 Parathyroid Hormone 1-84, human, recombinant (1st International Standard)
International Standard
95/650 Interferon alpha-2a (Human, rDNA derived) WHO International Standard
International Standard
95/656 Interferon alpha 2b (Human rDNA derived)(3rd International Standard)
International Standard
95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)
Non WHO Reference Material
95/674 Anti-Meningococcal Serogroup A mAb
Non WHO Reference Material
95/678 Anti-Meningococcal Serogroup C mAb
Non WHO Reference Material
96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)
Non WHO Reference Material
96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
96/538 Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent
International Reference Reagent
96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard
International Standard
96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent
International Reference Reagent
96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent
International Reference Reagent
96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent
International Reference Reagent
96/602 Luteinizing Hormone, Human, recombinant WHO International Standard
International Standard
96/784 Inhibin B, Human WHO Reference Reagent
International Reference Reagent
96/836 Influenza Virus infectious RESVIR-9 (H3N2)
Influenza
96/850 Influenza Virus infectious NIB-39 (H1N1)
Influenza
97/518 Influenza Antigen A/Johannesburg/82/96
Influenza
97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum
Non WHO Reference Material
97/550 Islet Cell Antibodies WHO Reference Reagent
International Reference Reagent
97/558 Bordetella pertussis anti 69kD serum (sheep)
Non WHO Reference Material
97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)
International Standard
97/564 Bordetella pertussis anti FHA serum (sheep)
Non WHO Reference Material
97/572 Bordetella pertussis PT anti serum (sheep)
Non WHO Reference Material
97/574 Bordetella pertussis anti Fim3 serum (sheep)
Non WHO Reference Material
97/584 Influenza Antigen A/Equine/Newmarket/2/93
Influenza
97/594 Leptin, Human, Recombinant WHO International Standard
International Standard
97/596 Influenza Antigen A/Equine/Newmarket/1/93
Influenza
97/600 Interleukin-2 Soluble Receptor (human, rDNA derived)
Non WHO Reference Material
97/610 Influenza anti A/equine/Newmarket/1/93 Serum
Influenza
97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum
Influenza
97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)
Influenza
97/626 Leptin, Mouse, Recombinant WHO International Standard
International Standard
97/642 Bordetella pertussis anti serum (mouse) 1RR
International Standard
97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard
International Standard
97/648 Anti-Measles serum (3rd International Standard)
International Standard
97/692 Influenza Virus infectious IVR-108 (H3N2)
Influenza
97/714 Prolactin, Human, recombinant. WHO Reference Reagent
International Reference Reagent
97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)
Influenza
97/748 Influenza Antigen B/Harbin/7/94
Influenza
97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent
International Reference Reagent
97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard
International Standard
97/760 Influenza Antigen A/Beijing/262/95
Influenza
98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard
International Standard
98/544 Influenza Virus infectious RESVIR-13 (H3N2)
Influenza
98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum
Non WHO Reference Material
98/574 Somatropin WHO International Standard
International Standard
98/580 Prolactin Human, recombinant, glycosylated WHO Reference Reagent
International Reference Reagent
98/582 Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent
International Reference Reagent
98/586 Calcitonin, Salmon. WHO International Standard
International Standard
98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent
International Reference Reagent
98/600 Influenza Virus infectious NIB-40 (H5N3)
Influenza
98/604 Influenza anti B/Harbin/7/94/HA Serum
Influenza
98/610 Influenza Virus infectious ARIV-1 (H5N3)
Influenza
98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)
Influenza
98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)
Non WHO Reference Material
98/708 Haemiglobincyanide WHO International Standard
International Standard
98/714 Tissue Plasminogen Activator, Human, Recombinant WHO International Standard
International Standard
98/718 Neurotrophin 3
Non WHO Reference Material
98/762 Influenza Virus infectious Resvir-14 (H3N2)
Influenza
98/772 Influenza anti A/Beijing/262/95 Serum
Influenza
98/774 Influenza Antigen B/Shangdong/7/97
Influenza
98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2)
Influenza
99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7)
Non WHO Reference Material
99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7)
Non WHO Reference Material
99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11)
Non WHO Reference Material
99/512 Anti-PT S1 subunit Monoclonal Antibody (10D6)
Non WHO Reference Material
99/514 Anti-PT S1 subunit Monoclonal Antibody (8G4)
Non WHO Reference Material
99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E)
Non WHO Reference Material
99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E)
Non WHO Reference Material
99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10)
Non WHO Reference Material
99/522 Anti-PT S1 subunit Monoclonal Antibody (11D9)
Non WHO Reference Material
99/524 Anti-PT S1 subunit Monoclonal Antibody (4D10)
Non WHO Reference Material
99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6)
Non WHO Reference Material
99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9)
Non WHO Reference Material
99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5)
Non WHO Reference Material
99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A)
Non WHO Reference Material
99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6)
Non WHO Reference Material
99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12)
Non WHO Reference Material
99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3)
Non WHO Reference Material
99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8)
Non WHO Reference Material
99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10)
Non WHO Reference Material
99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11)
Non WHO Reference Material
99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5)
Non WHO Reference Material
99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12)
Non WHO Reference Material
99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8)
Non WHO Reference Material
99/552 Anti-PT S3 subunit Monoclonal Antibody (10B8)
Non WHO Reference Material
99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2)
Non WHO Reference Material
99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3)
Non WHO Reference Material
99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8)
Non WHO Reference Material
99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3)
Non WHO Reference Material
99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2)
Non WHO Reference Material
99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6)
Non WHO Reference Material
99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6)
Non WHO Reference Material
99/568 Anti-PT S5 subunit Monoclonal Antibody (7E3)
Non WHO Reference Material
99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)
Non WHO Reference Material
99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)
Non WHO Reference Material
99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)
Non WHO Reference Material
99/586 Influenza Antigen B/Yamanashi/166/98
Influenza
99/614 Influenza Antigen A/Sydney/5/97
Influenza
99/616 Yellow Fever Vaccine. WHO International Standard
International Standard
99/624 Influenza Antigen A/Sydney/5/97
Influenza
99/642 Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent
International Reference Reagent
99/650 Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent
International Reference Reagent
99/666 Anti-HPA-5b (Minimum Potency) WHO Reference Reagent
International Reference Reagent
99/674 HIV-2 (antibody) Monitor Sample
European Certification
99/688 Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent
International Reference Reagent
99/692 Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent
International Reference Reagent
99/706 Anti-Meningococcal human reference serum CDC1992
Non WHO Reference Material
99/708 Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent
International Reference Reagent
99/710 Anti-HIV 1 (1 in 5 BWS)
European Certification
99/714 Influenza Antigen A/Singapore/1/57 (H2N2)
Influenza
99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified)
International Standard
99/750 British Working Standard for Anti-HIV 1
European Certification
99/824 Influenza Virus infectious RESVIR 16 (H3N2)
Influenza
99/828 Influenza Antigen B/Yamanashi/166/98
Influenza
99/836 Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard
International Standard
AFP Alpha-Foetoprotein. WHO International Standard
International Standard
BUSB Botulinum Antitoxin Equine Type B. WHO International Standard
International Standard
CDS Anti-Canine Distemper Serum. WHO International Standard
International Standard
CHAN Cholera Antitoxin, Goat. WHO International Standard
International Standard
CHS Anti-Canine Hepatitis Serum
International Standard
COT Clostridium novyi (alpha) Toxoid. WHO Reference Reagent
International Reference Reagent
CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent
International Reference Reagent
CWEPSILTD Clostridium Welchii (Perfringens) (Epsilon) toxoid
International Standard
DY Anti-Dysentery (shiga) serum, Equine. WHO International Standard
International Standard
HBOHA Lyophilised HBO-HA Antigen for ELISA, Lot 17
Non WHO Reference Material
JNIH-11 Bordetella pertussis anti FHA serum (mouse)
Non WHO Reference Material
JNIH-12 Bordetella pertussis PT( LPF) anti serum, (mouse)
Non WHO Reference Material
JNIH-3 Acellular Pertussis Vaccine - 1st IS.
International Standard
JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA)
Non WHO Reference Material
MEF/001 Primary Mouse Embryo Fibroblasts (p0)
UK Stem Cell Bank
MGDS Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent
International Reference Reagent
NDS Anti-Newcastle Disease Serum. WHO International Standard
International Standard
NVIA Newcastle Disease Vaccine (Inactivated) WHO International Standard
International Standard
OE Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard
International Standard
PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard
International Standard
PPDA Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
International Standard
PPDBOV Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard)
International Standard
PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard
International Standard
QF Anti-Q Fever Serum, Bovine WHO International Standard
International Standard
RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016.
International Standard
RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.
International Standard
RUBI-1-94 Anti-rubella Immunoglobulin, Human WHO International Standard
International Standard
SES Swine Erysipelas Serum (anti-N) WHO Reference Reagent
International Reference Reagent
SFS Anti-Swine Fever Serum WHO International Standard
International Standard
SMV Smallpox Vaccine WHO International Standard
International Standard
SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard
International Standard
SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard
International Standard
SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent
International Reference Reagent
SS-319/20 FITC CD4 Positive Control Cells
Non WHO Reference Material
SSCLOT5 SSC Secondary Coagulation Standard Lot#5
Non WHO Reference Material
STA Staphylococcus Alpha Antitoxin, Equine WHO International Standard
International Standard
STT Diphtheria (Schick) Test Toxin WHO International Standard
International Standard
TILI Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard
International Standard
TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard
International Standard
TYVK Typhoid Vaccine (acetone-inactivated) WHO International Standard
International Standard
TYVL Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard
International Standard
VI Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard
International Standard
W1004 Anti-C complete blood typing serum,human WHO International Standard
International Standard
W1005 Anti-E complete blood typing serum, human WHO International Standard
International Standard
W1007 Anti-c Incomplete blood typing serum, human WHO International Standard
International Standard
W1044 Anti-Varicella zoster immunoglobulin WHO International Standard
International Standard
W1062 Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent
International Reference Reagent
W1063 Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent
International Reference Reagent
W1064 Anti-Nuclear factor serum,homogenous(66/233)
Non WHO Reference Material
YF Anti-Yellow Fever Serum, monkey WHO Reference Reagent
International Reference Reagent
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookie information
  • Sitemap